02.12.2023 | Tracker

Top 50 Pharma Tracker: eHCPs share news of Eli Lilly’s Zepbound FDA approval

By Aman Jandu

Discover what healthcare professionals (eHCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are eHCPs responding to drug launch news? How are eHCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of eHCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by eHCPs on X

November
Rank
October
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer4,2325298
22Moderna2,6891200
35AstraZeneca79331710
44Johnson & Johnson72829021
56GSK58118341
67Novo Nordisk39025211
713Bayer38410617
816Lilly3832890
93Novavax373675
1015Abbott2502353
1112Roche2368421
1210Sanofi23310224
1338Vertex2122124
149Gilead Sciences206831
1511Novartis20511012
168BioNTech176170
1718AbbVie14011019
1819Amgen117842
1920Takeda1151070
2014Merck & Co986616
2117BMS94741
2235Viatris6310
2329Otsuka61110
2421Boehringer Ingelheim57431
2527Organon4810
2623Regeneron43182
2722Fresenius41248
2833UCB36299
2925Daiichi Sankyo35171
3032Astellas33260
3137Ipsen26180
3231Teva24191
3326Eisai2081
3328Merck KGaA20191
3530Servier1987
3639Grifols1850
3736Bausch1650
3843Incyte15130
3934Biogen1061
4040Menarini850
4124CSL771
4241Chugai533
4244Horizon550
4442Jazz Pharmaceuticals420
4550Perrigo210
5045CSPC000
5046Sun000
5050Sino000
5050Shanghai000
5050Jiangsu Hengrui000

The latest insights from eHCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by eHCPs on X in November 2023 were Pfizer, Moderna, AstraZeneca, Johnson & Johnson, and GSK.

CREATION.co identified 11,169 eHCP mentions of pharmaceutical companies in November 2023, decreasing by 13% over the previous month.

On 08 November, Eli Lilly announced it had received FDA approval for the chronic weight management drug, “Zepbound”. eHCPs took the opportunity to share the news with their peers – calling the drug “remarkable”.

Clinician Scientist Daniel J. Drucker shared the news, describing it as “the most effective GLP-1 based medicine to date”.

Abbott hosted a series of cardiology training sessions this month, following their sessions delivered in October. On 20 November, cardiologist Ian McLeod shared a short overview of the event, sharing how he “really enjoyed” partnering with Abbott in the delivery of the sessions.

The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:

  1. A press release from Eli Lilly sharing the FDA approval of Zepbound.
  2. A Nobel Prize article honouring Katalin Karikó and Drew Weissman for their discoveries, enabling the development of mRNA COVID-19 vaccines.
  3. A poster by ASE for Cardiac Amyloidosis, developed in collaboration with Pfizer.

CREATION.co continues to analyse online eHCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

Methodology notes:

  • In November 2023, CREATION Pinpoint® identified 11,169 healthcare professional authored posts on X (Twitter) from 3,965 individual eHCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 30 November 2023.
  • Unless otherwise specified, mentions of a company are not limited to its X account(s).
  • In some cases, an X post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In November 2023, 56 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.

 

Top 50: https://creation.co/resources/hcp-insight-trackers/top-50-pharma-tracker/
Product approval: https://creation.co/resources/hcp-insight-trackers/product-launch-tracker/
All trackers: https://creation.co/resources/hcp-insight-trackers/

View all articles >

Meet the Author

Aman Jandu

With a background working in IT systems administration, and leveraging a 1st Class degree in Digital Technologies, Aman uses his technical skills to apply a systematic approach to gather data and analyse insights.

Aman loves to Speedcube. While he can currently solve a Rubik’s Cube in around 20 seconds, he is learning how to complete it blindfolded.

Suggested next


FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

11.02.2020 | Article

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

By Nathan Cripps

SGLT2 inhibitors: an emerging option for cardiologists?

05.09.2018 | Article

SGLT2 inhibitors: an emerging option for cardiologists?

SGLT2 inhibitors: an emerging option for cardiologists?

By Daniel Ghinn

View all articles >